Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
February 25, 2008 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 2,000 | $6.17 | 20,349 | |
October 2, 2018 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 5,100 | $2.70 | 20,787 | |
May 17, 2012 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 5,000 | $1.93 | 21,000 | |
May 30, 2017 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,429 | -- | 21,249 | |
November 16, 2005 | EVP, CFO | Form 4 | Open market or private purchase of non-derivative or derivative security | 21,300 | $0.29 | 21,300 | |
March 14, 2014 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 2,500 | $3.86 | 21,331 | |
April 13, 2010 | Interim Chief Accounting Off. | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 700 | -- | 21,400 | |
May 30, 2017 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,429 | -- | 21,429 | |
May 30, 2017 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,429 | -- | 21,429 | |
March 6, 2019 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,400 | $2.13 | 21,491 | |
May 30, 2017 | Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,786 | -- | 21,786 | |
June 13, 2022 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,250 | -- | 22,587 | |
May 26, 2011 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 8,636 | $2.77 | 23,636 | |
November 13, 2014 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 4,000 | $2.50 | 23,999 | |
May 16, 2019 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 4,000 | $2.15 | 24,000 | |
May 30, 2017 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 24,286 | -- | 24,286 | |
February 26, 2008 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 4,000 | $6.27 | 24,349 | |
July 6, 2010 | Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,000 | -- | 25,000 | |
February 19, 2010 | Interim CAO, Controller | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | $2.94 | 25,000 | |
December 8, 2008 | Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,000 | $3.00 | 25,000 | |
February 19, 2008 | Chief Accounting Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,500 | $5.50 | 25,000 | |
February 19, 2008 | Chief Accounting Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,500 | $5.50 | 25,000 | |
February 19, 2008 | Chief Accounting Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,500 | $5.50 | 25,000 | |
February 19, 2008 | Chief Accounting Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,500 | $5.50 | 25,000 | |
November 14, 2005 | EVP, CFO | Form 4 | Open market or private purchase of non-derivative or derivative security | 25,000 | $0.32 | 25,000 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.